Elsevier

Lung Cancer

Volume 45, Issue 2, August 2004, Pages 263-266
Lung Cancer

CASE REPORT
Complete spontaneous remission of non-small-cell lung cancer: a case report

https://doi.org/10.1016/j.lungcan.2004.01.026Get rights and content

Abstract

Spontaneous remission (SR) of cancer is a rare event, particularly in lung cancer. We report the case of a 68-year-old man, who came to our attention with a diagnosis of poorly differentiated pulmonary adenocarcinoma and, in absence of any active therapy, underwent a durable complete SR.

Our case supports the rare occurrence of SR in non-small-cell lung cancer (NSCLC).

Introduction

Spontaneous remission (SR) of cancer, according to a generally accepted definition, is a complete or partial, temporary or permanent disappearance of all or at least some relevant parameters of a soundly diagnosed malignant disease, without any medical treatment or with treatment that is considered inadequate to produce the resulting regression. SR is an extremely rare event. Everson and Cole reported only 176 cases of SR from 1900 to 1964, with an estimated incidence of 1 out of 60,000–100,000 people with cancer [1], [2]. Although SR is seen sporadically in any type of cancer, it has been reported especially in a few types of tumours, where the host immune system is known to play an important role, as malignant melanoma, renal cell cancer, low-grade non-Hodgkins’s lymphoma, chronic lymphocytic leukaemia and neuroblastoma in children. SR is considered to be a particularly rare event in lung cancer [3]. Contemporary with the first observations of SR the interest was raised about the possible biological mechanisms involved in this phenomenon, which unfortunately remains still unexplained.

Section snippets

Discussion

A 68-year-old Caucasian man was admitted to the hospital in October 1999, because of acute respiratory insufficiency without fever or signs of infection. The patient was a heavy smoker and had a past medical history of hypertension, emphysema, asthma, ischemic heart disease and nephroangiosclerosis. A thoracic computed tomography (CT) revealed the presence of a middle lobe 3 cm mass, with omogeneous contrast enhancement and without calcifications or peripheral retraction, suggesting a

Conclusion

SR of cancer is the disappearance of a malignant disease, without adequate treatment. SR, occasionally reported in few tumor types, is considered to be an exceptionally rare event in lung cancer, in spite of its global high incidence. Kappauf, in his review of the literature [3], reports only 11 cases of SR in NSCLC. In this series some patients had undergone surgery, with residual non-resectable, or low dose radiotherapy, and obtained a SR, also after developing metastasis. Only three patients

References (5)

There are more references available in the full text version of this article.

Cited by (21)

  • Complete spontaneous regression of non-small cell lung cancer followed by adrenal relapse

    2011, Chest
    Citation Excerpt :

    According to their definition, SR is a complete or partial disappearance of disease continuing for > 1 month without effective anticancer treatments. Although this rare phenomenon has been documented in patients with several types of malignancies, including malignant melanoma, renal cell carcinoma, neuroblastoma, and hepatocellular carcinoma, it is rarely observed in patients with lung cancer.2–4 Kumar et al2 reviewed 782 documented SR cases and identified only five SR cases of primary thoracic malignancies, which included two cases of bronchogenic carcinomas.

  • Tumor risk by tissue engineering: cartilaginous differentiation of mesenchymal stem cells reduces tumor growth

    2010, Osteoarthritis and Cartilage
    Citation Excerpt :

    The tumor risk for immunocompromised patients is set 90-fold for lymphoma, 37-fold for malignant melanoma and 14-fold for cervical cancer21–24. One should also recapitulate case reports that showed spontaneous tumor regression in immunocompetent patients with prior diagnosis of bronchial carcinoma, gut tumors, malignant melanoma or breast cancer37–41. For review see Blattman and Greenberg42.

View all citing articles on Scopus
View full text